Retracted: Liquid chromatography-tandem mass spectrometry and confirmation by liquid chromatography-high-resolution mass spectrometry hair tests to evidence use of tizanidine by racing cyclists.

[1]  J. Raul,et al.  LC/MS-MS and confirmation by LC/HRMS hair tests to evidence use of tizanidine by racing cyclists. , 2021, Drug testing and analysis.

[2]  J. Raul,et al.  Evidence of repeated mirtazapine poisoning in children by hair analysis , 2021, Journal of forensic sciences.

[3]  J. Raul,et al.  Characterization of letrozole in human hair using LC-MS/MS and confirmation by LC-HRMS: Application to a doping case. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  P. Kintz.  What Are The Prerequisites To Account For "No Fault" In Doping Control After An Adverse Analytical Finding Possibly Due To Drug Contamination? Perspective From A Hair Testing Analyst. , 2020, Journal of analytical toxicology.

[5]  A. Kaye,et al.  Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy. , 2020, Psychopharmacology bulletin.

[6]  J. Mariani,et al.  New directions in the treatment of opioid withdrawal , 2020, The Lancet.

[7]  J. Raul,et al.  Testing for GW501516 (cardarine) in human hair using LC/MS-MS and confirmation by LC/HRMS. , 2020, Drug testing and analysis.

[8]  J. Raul,et al.  Hair testing for doping agents. What is known and what remains to do. , 2020, Drug testing and analysis.

[9]  L. Mancl,et al.  A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment , 2018, The American journal of drug and alcohol abuse.

[10]  T. Partonen,et al.  Non‐medical use of psychoactive prescription drugs is associated with fatal poisoning , 2018, Addiction.

[11]  P. Kintz.  Hair Analysis in Forensic Toxicology: An Updated Review with a Special Focus on Pitfalls. , 2018, Current pharmaceutical design.

[12]  H. Kulaçoğlu,et al.  Tizanidine for the management of acute postoperative pain after inguinal hernia repair: A placebo-controlled double-blind trial , 2016, European journal of anaesthesiology.

[13]  R. Khalil.  Tizanidine for alcohol withdrawal treatment. , 2011 .

[14]  G. Malanga,et al.  Update on tizanidine for muscle spasticity and emerging indications , 2008 .

[15]  K. Wesnes,et al.  Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. , 2006, Clinical therapeutics.

[16]  S. Maurya,et al.  Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[17]  B. Levine,et al.  Tizanidine distribution in a postmortem case. , 2006, Journal of analytical toxicology.

[18]  S. Karamursel,et al.  Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain , 2005, International journal of clinical practice.

[19]  H. Spiller,et al.  Retrospective Review of Tizanidine (Zanaflex®) Overdose , 2004, Journal of toxicology. Clinical toxicology.

[20]  H. Yamamura,et al.  Effects of tizanidine in healthy volunteers: double-blind study compared with diazepam and a placebo. , 1988, International journal of clinical pharmacology research.